Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Orexigen
Orexigen
VC Financings Boost Interest in Biotech
Seeking Alpha
Fri, 07/24/09 - 09:41 am
biotech
venture capital
Human Genome Sciences
Orexigen
Medarex
ONYX Pharmaceuticals
Bristol-Myers Squibb
ImClone
Cell Therapeutics
Celera
Epix
FDA Calendar Updates: DDSS, HGSI, OREX, SPPI, TRIB
Seeking Alpha
Mon, 07/20/09 - 11:05 am
FDA
Spectrum Pharmaceuticals
Labopharm
Human Genome Sciences
Orexigen
Trinity Biotech
Orexigen obesity drug meets goals in 3 studies
Yahoo/AP
Mon, 07/20/09 - 10:35 am
Orexigen
Contrave
drug trials
obesity
Extreme FDA Trades: Another 18 Stocks Under 5 Bucks
Seeking Alpha
Sun, 07/5/09 - 08:42 am
Javelin
Acrux
Arena Pharmaceuticals
Cardium
Vivus
Orexigen
Biodel
Avanir
Alexza
Acadia
GenVec
Celsion
Antigenics
Osteotech
Transdel
pSivida
ARYx
Chelsea Therapeutics
CytRx
Human Genome Sciences
Orexigen licenses obesity drug-related patents
Yahoo/AP
Fri, 06/12/09 - 08:01 am
Orexigen
obesity
GSK
Contrave
NeuroSearch: Experimental Obesity Drug to Begin Phase 3 Trials
Seeking Alpha
Wed, 06/10/09 - 08:28 am
Neurosearch
obesity
Arena Pharmaceuticals
drug trials
Vivus
Orexigen
tesofensine
Orexigen's Contrave: Generic Would Be No Cheaper
Seeking Alpha
Mon, 04/6/09 - 08:38 am
generics
Orexigen
Contrave
obesity
Arena, The Aftermath
Seeking Alpha
Thu, 04/2/09 - 07:19 am
Arena Pharmaceuticals
obesity
Vivus
Orexigen
Contrave
Qnexa
Obesity Drug Arena's Heavy Burden
TheStreet.com
Mon, 03/23/09 - 09:43 am
obesity
Arena Pharmaceuticals
Vivus
fen phen
Orexigen
Wyeth
lorcaserin
Take Advantage of Market Confusion to Buy Orexigen Therapeutics
Seeking Alpha
Tue, 03/17/09 - 09:26 am
obesity
Orexigen
Contrave
Empatic
Eli Lilly
Arena Pharmaceuticals
Vivus
Arena Pharmaceuticals: Near Term Gamble May Be Worth It
Seeking Alpha
Tue, 03/10/09 - 07:36 am
Arena Pharmaceuticals
obesity
Qnexa
Vivus
Orexigen
Contrave
lorcaserin
Biopharma: Instead of M&A, Think P&A
Seeking Alpha
Thu, 03/5/09 - 08:19 am
Bristol-Myers Squibb
Forest Labs
Vertex Pharmaceuticals
Alexion
United Therapeutics
ImClone
Eli Lilly
Biodel
Cardiome
Elan
Inspire
Orexigen
Sucampo
Savient
Javelin
Vivus: A Bet on Well-Funded, Late-Stage Pipeline 3 comments
Seeking Alpha
Wed, 03/4/09 - 09:19 am
Vivus
pipelines
obesity
Arena Pharmaceuticals
Orexigen
[video]CNBC Exclusive: Orexigen CFO
CNBC
Wed, 01/14/09 - 09:54 am
Orexigen
Orexigen Tanks After-Hours on Obesity Data
TheStreet.com
Thu, 01/8/09 - 05:32 pm
Orexigen
obesity
Contrave
Orexigen to Post Obesity Data in Race With Vivus, Arena
TheStreet.com
Tue, 01/6/09 - 04:51 pm
Orexigen
obesity
Vivus
Arena Pharmaceuticals
Contrave
Qnexa
Biotech Clinical Trials to Watch in 2009
TheStreet.com
Thu, 12/18/08 - 03:43 pm
drug trials
Alnylam
Amgen
Amicus Therapeutics
Arena Pharmaceuticals
Biogen Idec
Chelsea Therapeutics
Genentech
Gilead Sciences
Human Genome Sciences
InterMune
Isis Pharmaceuticals
Neurocrine
ONYX Pharmaceuticals
Orexigen
Osiris Therapeutics
Poniard
Rigel
United Therapeutics
Synta
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17